Burcon Announces its Alliance Partner Completes Acquisition of Protein Production Facility
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) announces that its alliance partner, RE ProMan, , has completed the acquisition of a protein production facility in Galesburg, Illinois. The facility was chosen for its strategic location near agricultural growers and key transportation routes, as well as its existing processing capabilities that align with Burcon's protein technology platform.
The company plans to integrate its proprietary technologies into the facility and expects to begin commercial-scale production of protein products during the first half of 2025. This acquisition represents Burcon's first operational control of a commercial facility, positioning the company to deliver sustainable plant-based protein solutions to meet market demand.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) annuncia che il suo partner alleato, RE ProMan, ha completato l'acquisizione di un impianto di produzione di proteine a Galesburg, Illinois. L'impianto è stato scelto per la sua posizione strategica vicino ai coltivatori agricoli e alle principali vie di trasporto, nonché per le sue capacità di lavorazione esistenti che si allineano con la piattaforma tecnologica proteica di Burcon.
L'azienda prevede di integrare le proprie tecnologie proprietarie nell'impianto e si aspetta di iniziare la produzione su scala commerciale di prodotti proteici durante la prima metà del 2025. Questa acquisizione rappresenta il primo controllo operativo di Burcon su un impianto commerciale, posizionando l'azienda per fornire soluzioni proteiche vegetali sostenibili per soddisfare la domanda del mercato.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) anuncia que su socio aliado, RE ProMan, ha completado la adquisición de una instalación de producción de proteínas en Galesburg, Illinois. La instalación fue elegida por su ubicación estratégica cerca de los agricultores y las principales rutas de transporte, así como por sus capacidades de procesamiento existentes que se alinean con la plataforma de tecnología de proteínas de Burcon.
La empresa planea integrar sus tecnologías patentadas en la instalación y espera comenzar la producción a escala comercial de productos proteicos durante la primera mitad de 2025. Esta adquisición representa el primer control operativo de Burcon sobre una instalación comercial, posicionando a la empresa para ofrecer soluciones de proteínas vegetales sostenibles que satisfagan la demanda del mercado.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF)는 제휴 파트너인 RE ProMan이 일리노이주 게일스버그에 있는 단백질 생산 시설을 인수 완료했다고 발표했습니다. 이 시설은 농업 재배자와 주요 교통 노선 근처에 위치한 전략적 위치와 Burcon의 단백질 기술 플랫폼과 일치하는 기존 가공 능력 때문에 선택되었습니다.
회사는 해당 시설에 자사의 독점 기술을 통합할 계획이며, 2025년 상반기 중 상업 규모의 단백질 제품 생산을 시작할 것으로 예상하고 있습니다. 이번 인수는 Burcon이 상업 시설에 대한 첫 운영 통제를 확보한 것으로, 시장 수요를 충족하기 위해 지속 가능한 식물 기반 단백질 솔루션을 제공할 수 있는 위치에 회사를 두게 됩니다.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) annonce que son partenaire d'alliance, RE ProMan, a terminé l'acquisition d'une installation de production de protéines à Galesburg, Illinois. L'installation a été choisie pour sa localisation stratégique près des agriculteurs et des principales routes de transport, ainsi que pour ses capacités de transformation existantes qui s'alignent sur la plateforme technologique de protéines de Burcon.
L'entreprise prévoit d'intégrer ses technologies propriétaires dans l'installation et s'attend à commencer la production à l'échelle commerciale de produits protéiques au cours de la première moitié de 2025. Cette acquisition représente le premier contrôle opérationnel de Burcon sur une installation commerciale, positionnant l'entreprise pour fournir des solutions de protéines végétales durables afin de répondre à la demande du marché.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) gibt bekannt, dass sein Allianzpartner RE ProMan die Übernahme einer Proteinproduktionsanlage in Galesburg, Illinois, abgeschlossen hat. Die Anlage wurde aufgrund ihrer strategischen Lage in der Nähe von Landwirtschaftsbetrieben und wichtigen Verkehrswegen sowie ihrer bestehenden Verarbeitungskapazitäten, die mit Burcons Proteintechnologieplattform übereinstimmen, ausgewählt.
Das Unternehmen plant, seine proprietären Technologien in die Anlage zu integrieren und erwartet, in der ersten Hälfte des Jahres 2025 mit der kommerziellen Produktion von Proteinprodukten zu beginnen. Diese Übernahme stellt Burcons erste operative Kontrolle über eine kommerzielle Anlage dar und positioniert das Unternehmen, um nachhaltige pflanzenbasierte Proteinlösungen zur Deckung der Marktnachfrage anzubieten.
- First-time operational control of a commercial production facility
- Strategic location near agricultural suppliers and transportation routes
- Facility already equipped with compatible processing capabilities
- Clear timeline for commercial production in H1 2025
- None.
Vancouver, British Columbia--(Newsfile Corp. - March 10, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, proudly announces that its alliance partner, RE ProMan, LLC ("ProMan"), has successfully completed the acquisition of a protein production facility located in Galesburg, Illinois (the "Transaction").
"We are thrilled to complete this Transaction ahead of schedule and begin integrating Burcon's technologies into the facility," said John Vassallo, a Burcon director. "The Galesburg facility was our top choice, offering the infrastructure needed to bring Burcon's innovative protein products to market."
The Galesburg facility is equipped with processing capabilities aligned with Burcon's core protein technology platform. Located near agricultural growers and key transportation routes, Burcon believes it is ideally positioned for efficient production and distribution. Burcon expects to complete installation of proprietary unit operations and begin commercial-scale production of its protein products during the first half of 2025.
"This marks a watershed moment for Burcon," said Kip Underwood, Burcon's chief executive officer. "With this facility, we now have a clear path to market for our industry-leading protein products. We've already begun the operational transition, with our processing team on-site right now."
For the first time, Burcon has full operational control of a commercial facility, enabling the delivery of high-quality, sustainable plant-based protein solutions that meet growing consumer demand. By leveraging its proprietary technologies and industry expertise, Burcon aims to accelerate market adoption of its innovative protein ingredients to drive revenue growth.
About Burcon NutraScience Corporation
Burcon is a global technology leader in the development of plant-based proteins for foods and beverages. Our proteins exhibit superior functionality, taste and nutrition, making them ideal ingredients for food formulators. With over two decades of experience, Burcon has amassed an extensive patent portfolio covering its novel plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. Burcon is committed to delivering next-generation, best-in-class protein solutions, positioning itself as a key player in the rapidly expanding plant-based market. Supporting the growing trend towards a plant-based diet, Burcon offers sustainable protein ingredients that we believe are better for you and better for the planet. For more information, visit www.burcon.ca.
Forward-Looking Information Cautionary Statement
The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as "anticipate," "aim", "intend," "plan," "goal," "project," "estimate," "expect," "believe," "future," "likely," "may," "should," "could," "will" and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations, and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form for the year ended March 31, 2024 and its other public filings with Canadian securities regulators on SEDAR+ at www.sedarplus.ca. This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.
Industry and Investor Contact
Paul Lam
Director, Investor Relations and Communications
Burcon NutraScience Corporation
490 - 999 West Broadway, Vancouver, BC, V5Z 1K5
Tel (604) 733-0896, Toll-free (888) 408-7960
plam@burcon.ca www.burcon.ca
Media Contact:
Steve Campbell, APR
President
Campbell & Company Public Relations
Tel (604) 888-5267
TECH@CCOM-PR.COM
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/243899
FAQ
When will Burcon (BRCNF) begin commercial production at the Galesburg facility?
Where is Burcon's newly acquired protein production facility located?
What is the strategic importance of the Galesburg facility acquisition for BRCNF?
How will the Galesburg facility acquisition impact Burcon's production capabilities?
